Company intelligence / Profile preview

PharmaRhythm

La Jolla, California, United States

Ownership: Private
Development stage: Other

Overview

PharmaRhythm is a San Diego-based biotechnology company focused on developing novel therapeutics that target the circadian clock to treat metabolic and inflammatory diseases. Founded by leading experts in circadian biology from the Salk Institute, the company leverages a proprietary platform to identify small molecule modulators of core clock proteins such as Cryptochrome and REV-ERB. Their research aims to restore healthy circadian rhythms to address conditions like obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH). PharmaRhythm operates in the emerging field of chronotherapy, seeking to optimize drug efficacy and safety by aligning treatment with the body's natural biological cycles.

Therapeutic areas: EndocrinologyGastroenterologyMetabolic DisordersImmunology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on PharmaRhythm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaRhythm.

Explore the full profile